Verastem Cash on Hand 2011-2024 | VSTM

Verastem cash on hand from 2011 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Verastem Annual Cash on Hand
(Millions of US $)
2023 $137
2022 $88
2021 $100
2020 $141
2019 $76
2018 $250
2017 $87
2016 $81
2015 $110
2014 $93
2013 $101
2012 $57
2011 $48
2010 $4
Verastem Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $110
2023-12-31 $137
2023-09-30 $166
2023-06-30 $183
2023-03-31 $111
2022-12-31 $88
2022-09-30 $104
2022-06-30 $94
2022-03-31 $106
2021-12-31 $100
2021-09-30 $103
2021-06-30 $108
2021-03-31 $121
2020-12-31 $141
2020-09-30 $180
2020-06-30 $130
2020-03-31 $135
2019-12-31 $76
2019-09-30 $160
2019-06-30 $187
2019-03-31 $212
2018-12-31 $250
2018-09-30 $146
2018-06-30 $169
2018-03-31 $64
2017-12-31 $87
2017-09-30 $60
2017-06-30 $58
2017-03-31 $73
2016-12-31 $81
2016-09-30 $87
2016-06-30 $93
2016-03-31 $100
2015-12-31 $110
2015-09-30 $120
2015-06-30 $132
2015-03-31 $132
2014-12-31 $93
2014-09-30 $93
2014-06-30 $99
2014-03-31 $106
2013-12-31 $101
2013-09-30 $100
2013-06-30 $57
2013-03-31 $67
2012-12-31 $57
2012-09-30 $47
2012-06-30 $39
2012-03-31 $41
2011-12-31 $48
2011-09-30
2011-06-30
2011-03-31
2010-12-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.088B $0.003B
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company's defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $162.690B 16.28
Vertex Pharmaceuticals (VRTX) United States $122.237B 31.45
Regeneron Pharmaceuticals (REGN) United States $115.185B 28.17
CSL (CSLLY) Australia $92.804B 0.00
GSK (GSK) United Kingdom $84.265B 10.06
Bristol Myers Squibb (BMY) United States $83.050B 39.02
Gilead Sciences (GILD) United States $80.071B 15.95
Moderna (MRNA) United States $52.849B 0.00
Biogen (BIIB) United States $32.972B 15.10
Argenex SE (ARGX) Netherlands $22.483B 0.00
BioNTech SE (BNTX) Germany $21.024B 176.88
Alnylam Pharmaceuticals (ALNY) United States $19.897B 0.00
Illumina (ILMN) United States $17.375B 123.94
Genmab (GMAB) Denmark $17.048B 19.98
BioMarin Pharmaceutical (BMRN) United States $16.144B 62.98
BeiGene (BGNE) Cayman Islands $15.272B 0.00
Incyte (INCY) United States $14.076B 21.77
Bio-Techne Corp (TECH) United States $11.789B 44.53
Sarepta Therapeutics (SRPT) United States $11.043B 973.58
QIAGEN (QGEN) Netherlands $9.979B 21.32
Insmed (INSM) United States $9.615B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Roivant Sciences (ROIV) United Kingdom $7.919B 0.00
Vaxcyte (PCVX) United States $7.820B 0.00
Exact Sciences (EXAS) United States $7.627B 0.00
Legend Biotech (LEGN) United States $7.565B 0.00
Intra-Cellular Therapies (ITCI) United States $7.271B 0.00
Ascendis Pharma (ASND) Denmark $7.255B 0.00
Repligen (RGEN) United States $6.948B 90.77
Exelixis (EXEL) United States $6.604B 34.03
Blueprint Medicines (BPMC) United States $6.504B 0.00
Halozyme Therapeutics (HALO) United States $6.320B 17.55
Viking Therapeutics (VKTX) United States $5.736B 0.00
Cytokinetics (CYTK) United States $5.534B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.247B 0.00
Krystal Biotech (KRYS) United States $5.075B 0.00
Nuvalent (NUVL) United States $4.982B 0.00
Apellis Pharmaceuticals (APLS) United States $4.895B 0.00
Zealand Pharma (ZLDPF) Denmark $4.822B 0.00
Alkermes (ALKS) Ireland $4.232B 16.56
ImmunityBio (IBRX) United States $4.032B 0.00
Immunovant (IMVT) United States $3.914B 0.00
Avidity Biosciences (RNA) United States $3.787B 0.00
Guardant Health (GH) United States $3.732B 0.00
Axsome Therapeutics (AXSM) United States $3.610B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.309B 0.00
Merus (MRUS) Netherlands $3.273B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.116B 0.00
Amicus Therapeutics (FOLD) United States $2.974B 0.00
Denali Therapeutics (DNLI) United States $2.921B 0.00
Biohaven (BHVN) United States $2.913B 0.00
Arcellx (ACLX) United States $2.876B 0.00
Twist Bioscience (TWST) United States $2.853B 0.00
IDEAYA Biosciences (IDYA) United States $2.843B 0.00
Geron (GERN) United States $2.770B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.762B 0.00
MorphoSys AG (MOR) Germany $2.756B 0.00
SpringWorks Therapeutics (SWTX) United States $2.717B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.566B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.510B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.452B 0.00
Intellia Therapeutics (NTLA) United States $2.428B 0.00
ADMA Biologics Inc (ADMA) United States $2.420B 94.91
Certara (CERT) United States $2.311B 53.22
Celldex Therapeutics (CLDX) United States $2.301B 0.00
Apogee Therapeutics (APGE) United States $2.279B 0.00
Structure Therapeutics (GPCR) United States $2.265B 0.00
Iovance Biotherapeutics (IOVA) United States $2.261B 0.00
CG Oncology (CGON) United States $2.248B 0.00
Myriad Genetics (MYGN) United States $2.175B 0.00
Fortrea Holdings (FTRE) United States $2.151B 26.44
Janux Therapeutics (JANX) United States $2.078B 0.00
Vericel (VCEL) United States $2.027B 0.00
Beam Therapeutics (BEAM) United States $1.978B 0.00
Novavax (NVAX) United States $1.973B 0.00
Vera Therapeutics (VERA) United States $1.954B 0.00
Kymera Therapeutics (KYMR) United States $1.952B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.925B 0.00
Protagonist Therapeutics (PTGX) United States $1.904B 13.31
Zai Lab (ZLAB) China $1.883B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.850B 0.00
Bavarian Nordic (BVNRY) Denmark $1.769B 7.70
Arvinas (ARVN) United States $1.707B 0.00
Galapagos (GLPG) Belgium $1.696B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.690B 0.00
NeoGenomics (NEO) United States $1.673B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.668B 12.71
Edgewise Therapeutics (EWTX) United States $1.622B 0.00
Keros Therapeutics (KROS) United States $1.609B 0.00
Akero Therapeutics (AKRO) United States $1.584B 0.00
Kura Oncology (KURA) United States $1.576B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.555B 0.00
Neumora Therapeutics (NMRA) United States $1.496B 0.00
Dynavax Technologies (DVAX) United States $1.484B 189.00
Belite Bio (BLTE) United States $1.478B 0.00
Arcus Biosciences (RCUS) United States $1.473B 0.00
Ligand Pharmaceuticals (LGND) United States $1.452B 23.72
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.346B 0.00
Sana Biotechnology (SANA) United States $1.329B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.315B 0.00
Morphic Holding (MORF) United States $1.308B 0.00
ANI Pharmaceuticals (ANIP) United States $1.296B 16.09
MannKind (MNKD) United States $1.294B 158.33
Vir Biotechnology (VIR) United States $1.249B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.147B 0.00
Disc Medicine (IRON) United States $1.109B 0.00
Immatics (IMTX) Germany $1.101B 0.00
Cullinan Therapeutics (CGEM) United States $1.096B 0.00
Prothena (PRTA) Ireland $1.095B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.090B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.051B 0.00
Spyre Therapeutics (SYRE) United States $1.024B 0.00
Liquidia Technologies (LQDA) United States $1.018B 0.00
MiMedx (MDXG) United States $1.014B 42.94
Tango Therapeutics (TNGX) United States $1.002B 0.00
Gyre Therapeutics (GYRE) United States $0.986B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.948B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.945B 0.00
Tyra Biosciences (TYRA) United States $0.933B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.921B 0.00
AbCellera Biologics (ABCL) Canada $0.900B 0.00
Rapport Therapeutics (RAPP) $0.898B 0.00
89BIO (ETNB) United States $0.872B 0.00
Abivax SA (ABVX) France $0.853B 0.00
Cogent Biosciences (COGT) United States $0.841B 0.00
Mesoblast (MESO) Australia $0.827B 0.00
Stoke Therapeutics (STOK) United States $0.813B 0.00
Immunome (IMNM) United States $0.789B 0.00
PureTech Health (PRTC) United States $0.780B 0.00
CureVac (CVAC) Germany $0.779B 0.00
Viridian Therapeutics (VRDN) United States $0.779B 0.00
Prime Medicine (PRME) United States $0.762B 0.00
HilleVax (HLVX) United States $0.760B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.758B 0.00
Nurix Therapeutics (NRIX) United States $0.752B 0.00
Cytek Biosciences (CTKB) United States $0.746B 0.00
Dianthus Therapeutics (DNTH) United States $0.741B 0.00
Humacyte (HUMA) United States $0.737B 0.00
WAVE Life Sciences (WVE) Singapore $0.734B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.732B 0.00
Nuvation Bio (NUVB) United States $0.724B 0.00
Scholar Rock Holding (SRRK) United States $0.700B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.685B 0.00
Pliant Therapeutics (PLRX) United States $0.676B 0.00
Olema Pharmaceuticals (OLMA) United States $0.664B 0.00
GH Research (GHRS) Ireland $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
AnaptysBio (ANAB) United States $0.639B 0.00
Castle Biosciences (CSTL) United States $0.630B 0.00
CARGO Therapeutics (CRGX) United States $0.627B 0.00
Praxis Precision Medicines (PRAX) United States $0.625B 0.00
ArriVent BioPharma (AVBP) United States $0.620B 0.00
Northwest Biotherapeutics (NWBO) United States $0.610B 0.00
Pharming Group (PHGUF) Netherlands $0.606B 0.00
Mineralys Therapeutics (MLYS) United States $0.606B 0.00
Zymeworks (ZYME) United States $0.604B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.596B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.596B 0.00
Arbutus Biopharma (ABUS) United States $0.577B 0.00
REGENXBIO (RGNX) United States $0.573B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
PepGen (PEPG) United States $0.563B 0.00
Travere Therapeutics (TVTX) United States $0.558B 0.00
Pharming Group (PHAR) Netherlands $0.554B 0.00
Applied Therapeutics (APLT) United States $0.552B 0.00
ITeos Therapeutics (ITOS) United States $0.551B 0.00
Third Harmonic Bio (THRD) United States $0.530B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.526B 0.00
Neurogene (NGNE) United States $0.519B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.516B 0.00
Terns Pharmaceuticals (TERN) United States $0.515B 0.00
Entrada Therapeutics (TRDA) United States $0.513B 24.14
Oric Pharmaceuticals (ORIC) United States $0.502B 0.00
Annexon (ANNX) United States $0.495B 0.00
MaxCyte (MXCT) United States $0.490B 0.00
Astria Therapeutics (ATXS) United States $0.485B 0.00
Allogene Therapeutics (ALLO) United States $0.481B 0.00
Replimune (REPL) United States $0.480B 0.00
Oculis Holding AG (OCS) Switzerland $0.476B 0.00
Avid Bioservices (CDMO) United States $0.475B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.469B 0.00
Adaptive Biotechnologies (ADPT) United States $0.463B 0.00
Celcuity (CELC) United States $0.456B 0.00
Cabaletta Bio (CABA) United States $0.452B 0.00
Voyager Therapeutics (VYGR) United States $0.449B 0.00
Alector (ALEC) United States $0.440B 0.00
Fulcrum Therapeutics (FULC) United States $0.435B 0.00
IGM Biosciences (IGMS) United States $0.431B 0.00
Urogen Pharma (URGN) United States $0.429B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.424B 0.00
Editas Medicine (EDIT) United States $0.417B 0.00
ACELYRIN, INC (SLRN) United States $0.417B 0.00
Cartesian Therapeutics (RNAC) United States $0.415B 0.00
Contineum Therapeutics (CTNM) United States $0.412B 0.00
Precigen (PGEN) United States $0.411B 0.00
Fate Therapeutics (FATE) United States $0.406B 0.00
AC Immune (ACIU) Switzerland $0.404B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.395B 0.00
TScan Therapeutics (TCRX) United States $0.393B 0.00
Scilex Holding (SCLX) United States $0.390B 0.00
Absci (ABSI) United States $0.386B 0.00
ALX Oncology Holdings (ALXO) United States $0.385B 0.00
Anika Therapeutics (ANIK) United States $0.379B 324.88
EnGene Holdings (ENGN) United States $0.377B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.370B 0.00
Aura Biosciences (AURA) United States $0.367B 0.00
Jasper Therapeutics (JSPR) United States $0.366B 0.00
Erasca (ERAS) United States $0.347B 0.00
Ocugen (OCGN) United States $0.345B 0.00
Kyverna Therapeutics (KYTX) United States $0.340B 0.00
Nautilus Biotechnology (NAUT) United States $0.321B 0.00
Anavex Life Sciences (AVXL) United States $0.316B 0.00
Emergent Biosolutions (EBS) United States $0.315B 0.00
Amarin (AMRN) Ireland $0.311B 0.00
Skye Bioscience (SKYE) United States $0.305B 0.00
Agenus (AGEN) United States $0.300B 0.00
Atea Pharmaceuticals (AVIR) United States $0.297B 0.00
Kamada (KMDA) Israel $0.297B 22.48
Alto Neuroscience (ANRO) United States $0.297B 0.00
Revance Therapeutics (RVNC) United States $0.292B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.288B 0.00
Solid Biosciences (SLDB) United States $0.287B 0.00
C4 Therapeutics (CCCC) United States $0.285B 0.00
Inozyme Pharma (INZY) United States $0.285B 0.00
MeiraGTx Holdings (MGTX) United States $0.282B 0.00
XOMA (XOMA) United States $0.282B 0.00
Nkarta (NKTX) United States $0.280B 0.00
Poseida Therapeutics (PSTX) United States $0.272B 0.00
Molecular Partners AG (MOLN) Switzerland $0.267B 0.00
Sutro Biopharma (STRO) United States $0.262B 0.00
Tenaya Therapeutics (TNYA) United States $0.259B 0.00
Mersana Therapeutics (MRSN) United States $0.250B 0.00
CorMedix Inc (CRMD) United States $0.247B 0.00
Shattuck Labs (STTK) United States $0.237B 0.00
Prima BioMed (IMMP) Australia $0.237B 0.00
Renovaro (RENB) United States $0.235B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.233B 0.00
Inovio Pharmaceuticals (INO) United States $0.232B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.231B 0.00
Q32 Bio (QTTB) United States $0.231B 0.00
UniQure (QURE) Netherlands $0.228B 0.00
Greenwich LifeSciences (GLSI) United States $0.225B 0.00
ChromaDex (CDXC) United States $0.224B 0.00
FibroBiologics (FBLG) United States $0.220B 0.00
Design Therapeutics (DSGN) United States $0.216B 0.00
Candel Therapeutics (CADL) United States $0.215B 0.00
Codexis (CDXS) United States $0.210B 0.00
2seventy Bio (TSVT) United States $0.210B 0.00
Inhibrx Biosciences (INBX) $0.205B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
23andMe Holding (ME) United States $0.196B 0.00
Ventyx Biosciences (VTYX) United States $0.194B 0.00
Rani Therapeutics Holdings (RANI) United States $0.192B 0.00
Trevi Therapeutics (TRVI) United States $0.191B 0.00
Coherus BioSciences (CHRS) United States $0.188B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.185B 0.00
XBiotech (XBIT) United States $0.185B 0.00
Abeona Therapeutics (ABEO) United States $0.185B 0.00
Biomea Fusion (BMEA) United States $0.183B 0.00
Oncobiologics (OTLK) United States $0.177B 0.00
Invivyd (IVVD) United States $0.175B 0.00
Alimera Sciences (ALIM) United States $0.170B 0.00
Innate Pharma S.A (IPHA) France $0.170B 0.00
Compugen (CGEN) Israel $0.170B 0.00
X4 Pharmaceuticals (XFOR) United States $0.167B 0.00
INmune Bio (INMB) United States $0.164B 0.00
Zura Bio (ZURA) United States $0.163B 0.00
Elevation Oncology (ELEV) United States $0.163B 0.00
Repare Therapeutics (RPTX) Canada $0.161B 0.00
Compass Therapeutics (CMPX) United States $0.161B 0.00
Vigil Neuroscience (VIGL) United States $0.159B 0.00
Caribou Biosciences (CRBU) United States $0.158B 0.00
Lifecore Biomedical (LFCR) United States $0.156B 0.00
Rezolute (RZLT) United States $0.155B 0.00
Puma Biotechnology (PBYI) United States $0.154B 9.70
Syros Pharmaceuticals (SYRS) United States $0.153B 0.00
Adverum Biotechnologies (ADVM) United States $0.152B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.150B 0.00
I-Mab (IMAB) China $0.147B 0.00
ScPharmaceuticals (SCPH) United States $0.147B 0.00
Semper Paratus Acquisition (TVGN) United States $0.145B 0.00
Kodiak Sciences (KOD) United States $0.141B 0.00
Inventiva S.A (IVA) France $0.140B 0.00
G1 Therapeutics (GTHX) United States $0.140B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.138B 0.00
Boundless Bio (BOLD) United States $0.137B 0.00
TELA Bio (TELA) United States $0.137B 0.00
Werewolf Therapeutics (HOWL) United States $0.136B 0.00
Sagimet Biosciences (SGMT) United States $0.128B 0.00
Nuvectis Pharma (NVCT) United States $0.126B 0.00
ATyr Pharma (ATYR) United States $0.122B 0.00
Adlai Nortye (ANL) Cayman Islands $0.122B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.121B 0.00
Cardiff Oncology (CRDF) United States $0.119B 0.00
Cellectis S.A (CLLS) France $0.119B 0.00
Gossamer Bio (GOSS) United States $0.118B 0.00
Rapt Therapeutics (RAPT) United States $0.116B 0.00
CervoMed (CRVO) United States $0.115B 0.00
BioStem Technologies (BSEM) $0.115B 0.00
Seer (SEER) United States $0.111B 0.00
Adagene (ADAG) China $0.111B 0.00
Opthea (OPT) Australia $0.110B 0.00
BeyondSpring (BYSI) United States $0.109B 0.00
Adicet Bio (ACET) United States $0.108B 0.00
CytomX Therapeutics (CTMX) United States $0.107B 6.85
Akoya Biosciences (AKYA) United States $0.105B 0.00
Bluebird Bio (BLUE) United States $0.104B 0.00
Allakos (ALLK) United States $0.104B 0.00
Immunic (IMUX) United States $0.103B 0.00
Affimed (AFMD) Germany $0.103B 0.00
Omega Therapeutics (OMGA) United States $0.103B 0.00
Seres Therapeutics (MCRB) United States $0.102B 0.00
Athira Pharma (ATHA) United States $0.100B 0.00
Coya Therapeutics (COYA) United States $0.099B 0.00
BioHarvest Sciences (CNVCD) Canada $0.099B 0.00
PDS Biotechnology (PDSB) United States $0.098B 0.00
DBV Technologies S.A (DBVT) France $0.096B 0.00
VistaGen Therapeutics (VTGN) United States $0.092B 0.00
Connect Biopharma Holdings (CNTB) United States $0.091B 0.00
DiaMedica Therapeutics (DMAC) United States $0.091B 0.00
InflaRx (IFRX) Germany $0.089B 0.00
Clearside Biomedical (CLSD) United States $0.088B 0.00
Cognition Therapeutics (CGTX) United States $0.088B 0.00
Eton Pharmaceuticals (ETON) United States $0.086B 83.75
Sangamo Therapeutics (SGMO) United States $0.086B 0.00
Ikena Oncology (IKNA) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Gritstone Bio (GRTS) United States $0.083B 0.00
Genelux (GNLX) United States $0.082B 0.00
Elicio Therapeutics (ELTX) United States $0.082B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.081B 0.00
IO Biotech (IOBT) Denmark $0.081B 0.00
Vor Biopharma (VOR) $0.080B 0.00
Elutia (ELUT) United States $0.077B 0.00
Oncolytics Biotech (ONCY) Canada $0.077B 0.00
Precision BioSciences (DTIL) United States $0.075B 0.00
BioAtla (BCAB) United States $0.075B 0.00
Entera Bio (ENTX) Israel $0.074B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.072B 0.00
Galena Biopharma (SLS) United States $0.072B 0.00
HOOKIPA Pharma (HOOK) United States $0.071B 0.00
Alpha Teknova (TKNO) United States $0.070B 0.00
Benitec Biopharma (BNTC) United States $0.070B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.070B 0.00
Aileron Therapeutics (ALRN) United States $0.069B 0.00
Spero Therapeutics (SPRO) United States $0.069B 2.51
LENZ Therapeutics (LENZ) United States $0.067B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.066B 0.00
AVROBIO (AVRO) United States $0.066B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
Instil Bio (TIL) United States $0.065B 0.00
Intensity Therapeutics (INTS) United States $0.064B 0.00
LakeShore Biopharma (LSB) China $0.064B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.064B 0.00
VTv Therapeutics (VTVT) United States $0.063B 0.00
Kronos Bio (KRON) United States $0.063B 0.00
Turnstone Biologics (TSBX) United States $0.062B 0.00
Passage Bio (PASG) United States $0.062B 0.00
Earth Science Tech (ETST) United States $0.062B 0.00
AN2 Therapeutics (ANTX) United States $0.062B 0.00
Annovis Bio (ANVS) United States $0.062B 0.00
Celularity (CELU) United States $0.060B 0.00
Rallybio (RLYB) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
Theratechnologies (THTX) Canada $0.059B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.058B 0.00
Dyadic (DYAI) United States $0.058B 0.00
Cidara Therapeutics (CDTX) United States $0.057B 0.00
Enzo Biochem (ENZ) United States $0.057B 0.00
Ovid Therapeutics (OVID) United States $0.056B 0.00
Bionano Genomics (BNGO) United States $0.054B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
Ocean Biomedical (OCEA) United States $0.054B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.053B 0.00
Leap Therapeutics (LPTX) United States $0.053B 0.00
Lantern Pharma (LTRN) United States $0.053B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.053B 0.00
CalciMedica (CALC) United States $0.052B 0.00
Atara Biotherapeutics (ATRA) United States $0.051B 0.00
BioXcel Therapeutics (BTAI) United States $0.050B 0.00
Curis (CRIS) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
Clene (CLNN) United States $0.048B 0.00
Aerovate Therapeutics (AVTE) United States $0.048B 0.00
Beyond Air (XAIR) United States $0.047B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Immuneering (IMRX) United States $0.046B 0.00
IN8bio (INAB) United States $0.044B 0.00
Dare Bioscience (DARE) United States $0.044B 0.00
Ocuphire Pharma (OCUP) United States $0.044B 0.00
Aadi Bioscience (AADI) United States $0.040B 0.00
NextCure (NXTC) United States $0.040B 0.00
HCW Biologics (HCWB) United States $0.039B 0.00
Carmell (CTCX) United States $0.038B 0.00
Fortress Biotech (FBIO) United States $0.038B 0.00
Lexaria Bioscience (LEXX) Canada $0.038B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Aligos Therapeutics (ALGS) United States $0.037B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Eyenovia (EYEN) United States $0.035B 0.00
RenovoRx (RNXT) United States $0.032B 0.00
NKGen Biotech (NKGN) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.032B 0.00
Quince Therapeutics (QNCX) United States $0.031B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.030B 0.00
Pluri (PLUR) Israel $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
Lisata Therapeutics (LSTA) United States $0.029B 0.00
BRIACELL THERAP (BCTX) Canada $0.027B 0.00
Spruce Biosciences (SPRB) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Equillium (EQ) United States $0.025B 0.00
Cocrystal Pharma (COCP) United States $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.023B 0.00
UNITY Biotechnology (UBX) United States $0.023B 0.00
BioAffinity Technologies (BIAF) United States $0.023B 0.00
Aprea Therapeutics (APRE) United States $0.023B 0.00
Femasys (FEMY) United States $0.022B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Orgenesis (ORGS) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
Forte Biosciences (FBRX) United States $0.019B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.019B 0.00
Lumos Pharma (LUMO) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Apollomics (APLM) United States $0.017B 0.00
VBI Vaccines (VBIV) United States $0.016B 0.00
KALA BIO (KALA) United States $0.016B 0.00
Aptose Biosciences (APTO) Canada $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Longeveron (LGVN) United States $0.015B 0.00
Sensei Biotherapeutics (SNSE) United States $0.015B 0.00
Monopar Therapeutics (MNPR) United States $0.015B 0.00
Biorestorative Therapies (BRTX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Cara Therapeutics (CARA) United States $0.014B 0.00
Galecto (GLTO) Denmark $0.014B 0.00
Purple Biotech (PPBT) Israel $0.014B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.013B 0.00
Evaxion Biotech (EVAX) Denmark $0.013B 0.00
Organovo Holdings (ONVO) United States $0.013B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.013B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
Senti Biosciences (SNTI) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Scorpius Holdings (SCPX) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.006B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Psyence Biomedical (PBM) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Entero Therapeutics (ENTO) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.39
Onconetix (ONCO) United States $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Seelos Therapeutics (SEEL) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
CNS Pharmaceuticals (CNSP) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Mustang Bio (MBIO) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00